The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Role of Autoreactive B Cells in Rheumatoid Arthritis

The Role of Autoreactive B Cells in Rheumatoid Arthritis

September 17, 2019 • By Catherine Kolonko

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The body uses B cells to produce antibodies that can fight off infection by invading antigens and bacteria. But in rheumatoid arthritis (RA), the immune system produces autoantibodies that work against the body’s proteins to attack joint tissues. Researchers believe this process is helped along by autoreactive B cells that live in bone matter and release proinflammatory cytokines.

You Might Also Like
  • Characterization of Autoreactive B Cells in Patients with SLE & RA
  • Understanding the Role of Citrullination in Rheumatoid Arthritis
  • Plasma Cells, Synovial Compartment Implicated in Tenacity of Rheumatoid Arthritis
Explore This Issue
September 2019
Also By This Author
  • New Treatment Paradigm Suggested for Osteoarthritis

As part of a new study, researchers used ribonucleic acid (RNA) sequencing to obtain a comprehensive transcriptome profile of human citrulline-specific B cells in patients with RA.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The researchers investigated relationships between interleukin (IL) 15α and citrulline-specific B cells. They also studied the capability of B cells from RA patients to produce amphiregulin, a protein that is part of the epidermal growth factor (EGF) family and that stimulates differentiation and growth of cells. The findings, published in the journal Arthritis & Rheumatology, indicate the potential role B cells play in increased differentiation of cells responsible for eroding bone.

“Our results portray B cells as not merely autoantibody producers, but as a source of diverse molecules that can influence proliferation, differentiation and activation of other pathogenic cells types,” wrote Ankit Mahendra, PhD, the study’s lead author and a scientist employed by Sanofi. At the time of the study’s publication, he was a postdoctoral fellow at the University of Houston’s Department of Chemical and Biomolecular Engineering.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The Methods

In this study, the researchers investigated “if there are fundamental differences in the biology of the B cells themselves,” says senior author Navin Varadarajan, PhD, associate professor of chemical and biomolecular engineering at the University of Houston.

The research team compared three groups of cell types: autoreactive anti-cyclic citrullinated peptide (CCP) and rheumatoid factor positive (RA-CCPpos) B cells from RA patients; RA-CCP negative (RA-CCPneg) B cells from RA patients that were not autoreactive; and B cells from healthy donors who produced antibodies against influenza (hemagglutinin-specific/HA) after vaccination.

“We wanted to take an unbiased discovery approach to see what’s different about the biology of these B cells compared [with] B cells from healthy donors,” Dr. Varadarajan says. “We used RNA sequencing to understand differences in basic B cell biology between these different groups.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Hemagglutinin is a surface protein from influenza the researchers used to identify B cells likely to be reactive to influenza. Similarly, “autoantibodies in rheumatoid arthritis are reactive to citrullinated peptides,” says Dr. Varadarajan. “So you are using the citrullinated peptides to identify B cells that are autoreactive.”

Researchers isolated citrulline- and hemagglutinin-specific B cells using peptide-streptavidin conjugates from peripheral blood of RA patients and healthy controls. With messenger RNA (mRNA) serving as a surrogate for protein expression, the researchers conducted RNA sequencing of the sorted cells to obtain a transcriptome profile.

Key protein molecules were evaluated with aptamer-based proteomic assays and flow cytometry. In vitro functional assays were employed to study how the proteins affect differentiation of osteoclasts and proliferation and migration of synoviocytes, cells inside the synovium that are considered a hallmark of RA pathogenesis.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Research Reviews, Rheumatoid Arthritis Tagged With: amphiregulin, autoreactive B cellsIssue: September 2019

You Might Also Like:
  • Characterization of Autoreactive B Cells in Patients with SLE & RA
  • Understanding the Role of Citrullination in Rheumatoid Arthritis
  • Plasma Cells, Synovial Compartment Implicated in Tenacity of Rheumatoid Arthritis
  • Autoreactive Germinal Centers: A Single Autoreactive B Cell Clone Can Drive Autoimmunity

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.